SAFETY AND EFFICACY OF ORAL REGIMENS FOR THE TREATMENT OF HEPATITIS C GENOTYPE 1b INFECTION: HCV---TARGET INTERIM ANALYSIS OF A PROSPECTIVE, OBSERVATIONAL STUDY HCV-TARGET Study Group

Conference Reports for NATAP

(APASL) 25th Conference of the Asian Pacific
Association for the Study of the Liver
Feb 20-24 2016, Tokyo, Japan


SAFETY AND EFFICACY OF ORAL REGIMENS FOR THE TREATMENT OF HEPATITIS C GENOTYPE 1b INFECTION: HCV---TARGET INTERIM ANALYSIS OF A PROSPECTIVE, OBSERVATIONAL STUDY HCV-TARGET Study Group

	Reported by Jules Levin APASL 2016 Tokyo Feb 20-24